These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33636313)

  • 1. The AGE Reader: A non-invasive method to assess long-term tissue damage.
    Atzeni IM; van de Zande SC; Westra J; Zwerver J; Smit AJ; Mulder DJ
    Methods; 2022 Jul; 203():533-541. PubMed ID: 33636313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between habitual dietary and lifestyle behaviours and skin autofluorescence (SAF), a marker of tissue accumulation of advanced glycation endproducts (AGEs), in healthy adults.
    Kellow NJ; Coughlan MT; Reid CM
    Eur J Nutr; 2018 Sep; 57(6):2209-2216. PubMed ID: 28656390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is skin autofluorescence (SAF) representative of dermal advanced glycation endproducts (AGEs) in dark skin? A pilot study.
    Atzeni IM; Boersema J; Pas HH; Diercks GFH; Scheijen JLJM; Schalkwijk CG; Mulder DJ; van der Zee P; Smit AJ
    Heliyon; 2020 Nov; 6(11):e05364. PubMed ID: 33241137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin autofluorescence, a non-invasive marker of advanced glycation end products: clinical relevance and limitations.
    Da Moura Semedo C; Webb M; Waller H; Khunti K; Davies M
    Postgrad Med J; 2017 May; 93(1099):289-294. PubMed ID: 28143896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between the tissue accumulation of advanced glycation end products and exercise capacity in cardiac rehabilitation patients.
    Kunimoto M; Shimada K; Yokoyama M; Matsubara T; Aikawa T; Ouchi S; Shimizu M; Fukao K; Miyazaki T; Kadoguchi T; Fujiwara K; Abulimiti A; Honzawa A; Yamada M; Shimada A; Yamamoto T; Asai T; Amano A; Smit AJ; Daida H
    BMC Cardiovasc Disord; 2020 Apr; 20(1):195. PubMed ID: 32326893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin autofluorescence predicts major adverse cardiovascular events in patients with type 1 diabetes: a 7-year follow-up study.
    Blanc-Bisson C; Velayoudom-Cephise FL; Cougnard-Gregoire A; Helmer C; Rajaobelina K; Delcourt C; Alexandre L; Blanco L; Mohammedi K; Monlun M; Rigalleau V
    Cardiovasc Diabetol; 2018 Jun; 17(1):82. PubMed ID: 29884175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced glycation end products (AGEs) estimated by skin autofluorescence are related with cardiovascular risk in renal transplant.
    Calviño J; Cigarran S; Gonzalez-Tabares L; Menendez N; Latorre J; Cillero S; Millan B; Cobelo C; Sanjurjo-Amado A; Quispe J; Garcia-Enriquez A; Carrero JJ
    PLoS One; 2018; 13(8):e0201118. PubMed ID: 30067789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin autofluorescence, arterial stiffness and Framingham risk score as predictors of clinical outcome in chronic kidney disease patients: a cohort study.
    Mukai H; Svedberg O; Lindholm B; Dai L; Heimbürger O; Barany P; Anderstam B; Stenvinkel P; Qureshi AR
    Nephrol Dial Transplant; 2019 Mar; 34(3):442-448. PubMed ID: 29378035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of advanced glycation end products, evaluated by skin autofluorescence, with lifestyle habits in a general Japanese population.
    Isami F; West BJ; Nakajima S; Yamagishi SI
    J Int Med Res; 2018 Mar; 46(3):1043-1051. PubMed ID: 29322837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between cardiac tissue glycation and skin autofluorescence in patients with coronary artery disease.
    Hofmann B; Jacobs K; Navarrete Santos A; Wienke A; Silber RE; Simm A
    Diabetes Metab; 2015 Nov; 41(5):410-5. PubMed ID: 25553578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dermal factors influencing measurement of skin autofluorescence.
    Noordzij MJ; Lefrandt JD; Graaff R; Smit AJ
    Diabetes Technol Ther; 2011 Feb; 13(2):165-70. PubMed ID: 21284484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Glycation of lens proteins in diabetes and its non-invasive assessment - first experience in the Czech Republic].
    Škrha J; Šoupal J; Prázný M; Škrha J
    Vnitr Lek; 2015 Apr; 61(4):346-50. PubMed ID: 25894266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A physically active lifestyle is related to a lower level of skin autofluorescence in a large population with chronic-disease (LifeLines cohort).
    van de Zande SC; de Vries JK; van den Akker-Scheek I; Zwerver J; Smit AJ
    J Sport Health Sci; 2022 Mar; 11(2):260-265. PubMed ID: 32987221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced glycation end-products (AGEs) accumulation in skin: relations with chronic kidney disease-mineral and bone disorder.
    França RA; Esteves ABA; Borges CM; Quadros KRDS; Falcão LCN; Caramori JCT; Oliveira RB
    J Bras Nefrol; 2017; 39(3):253-260. PubMed ID: 28902232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reference values for the Chinese population of skin autofluorescence as a marker of advanced glycation end products accumulated in tissue.
    Yue X; Hu H; Koetsier M; Graaff R; Han C
    Diabet Med; 2011 Jul; 28(7):818-23. PubMed ID: 21204956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin autofluorescence of advanced glycation end-products relates to new cardiovascular events in type 2 diabetes: A longitudinal observational study.
    Alkhami F; Borderie G; Foussard N; Larroumet A; Blanco L; Barbet-Massin MA; Ferriere A; Ducos C; Mohammedi K; Fawaz S; Couffinhal T; Rigalleau V
    Diabetes Metab; 2024 Mar; 50(2):101524. PubMed ID: 38346471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of tissue accumulation levels of advanced glycation end products by skin autofluorescence: A novel marker of vascular complications in high-risk patients for cardiovascular disease.
    Yamagishi S; Fukami K; Matsui T
    Int J Cardiol; 2015 Apr; 185():263-8. PubMed ID: 25814214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin autofluorescence: an emerging biomarker in persons with kidney disease.
    Viramontes Hörner D; Taal MW
    Curr Opin Nephrol Hypertens; 2019 Nov; 28(6):507-512. PubMed ID: 31589190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum 25-hydroxyvitamin D
    Chen J; van der Duin D; Campos-Obando N; Ikram MA; Nijsten TEC; Uitterlinden AG; Zillikens MC
    Eur J Epidemiol; 2019 Jan; 34(1):67-77. PubMed ID: 30255328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin autofluorescence in children with and without obesity.
    Lentferink YE; van Teeseling L; Knibbe CAJ; van der Vorst MMJ
    J Pediatr Endocrinol Metab; 2019 Jan; 32(1):41-47. PubMed ID: 30530882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.